T

TRVI

Trevi Therapeutics

14.33

+1.52+11.87%
Closed19:30 11/06 EST
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE13.04/12.81
TODAY RANGE13.00-14.36
VOL2.55M
MARKET CAP2.04B
52 WEEK RANGE9.82-20.22
AVG VOL (3M)1.93M
% TURNOVER1.64%
TURNOVER--
P/E (TTM)-41.8272
% RANGE10.62%
EPS(TTM)-0.3426
P/E(FORWARD)-29.3113
P/B6.35
BVPS2.257
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.87B
SHARES OUTSTANDING142.48M
NEXT EARNINGS11/11-11/16
FREE FLOAT130.19M
LOT SIZE1
EX-DATE--
Feeds
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

TRVI

--

R

Regeneron Pharmaceuticals

REGN

+0.16%
904.35

G

GridAI Tech

GRDX

+5.35%
4.920

B

BIONTECH

BNTX

+1.92%
87.51

U

United Therapeutics Corp.

UTHR

-0.65%
562.02

V

Vertex Pharmaceuticals Inc

VRTX

+0.85%
547.09

S

Siga Technologie

SIGA

+4.38%
3.100

M

Moderna

MRNA

+5.27%
254.19

C

Charles Riv Labs Intl Inc

CRL

+7.83%
337.52

M

Medpace Holdings

MEDP

+2.86%
653.11

T

Talphera Inc

TLPH

+3.96%
1.050

I

ICON plc

ICLR

+1.53%
204.74

CBPO

--

I

Iqvia Hldgs Inc

IQV

+2.62%
271.83

MOLN

--

A

Arcturus Therape

ARCT

+10.58%
10.35

P

PRA Health

PRAH

0.00%
165.21

G

Gilead Sciences Inc

GILD

-0.41%
166.89

I

Incyte Corp

INCY

+1.39%
119.65

A

Aptevo Therapeutics Inc

APVO

-2.36%
1.240

B

Biospecifics

BSTC

+0.15%
88.53
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.